ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 70 filers reported holding ATHIRA PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,671 | -41.5% | 9,738 | -14.6% | 0.00% | -50.0% |
| Q2 2023 | $33,651 | +18.0% | 11,407 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $28,518 | -21.1% | 11,407 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $36,160 | -27.7% | 11,407 | -32.6% | 0.00% | -50.0% |
| Q3 2022 | $50,000 | -29.6% | 16,920 | -27.8% | 0.01% | -33.3% |
| Q2 2022 | $71,000 | -78.2% | 23,420 | -3.1% | 0.01% | -76.0% |
| Q1 2022 | $326,000 | +7.6% | 24,173 | +4.1% | 0.05% | +8.7% |
| Q4 2021 | $303,000 | +114.9% | 23,220 | +54.5% | 0.05% | +24.3% |
| Q3 2021 | $141,000 | -65.7% | 15,031 | -62.6% | 0.04% | -59.8% |
| Q2 2021 | $411,000 | -10.5% | 40,139 | +61.0% | 0.09% | -10.7% |
| Q1 2021 | $459,000 | -50.4% | 24,927 | -7.8% | 0.10% | -54.4% |
| Q4 2020 | $926,000 | +221.5% | 27,027 | +73.5% | 0.23% | +186.1% |
| Q3 2020 | $288,000 | – | 15,575 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |